Igor Splawski occupies the position of Chief Scientific Officer for CureVac NV and Chief Scientific Officer for CureVac AG (a subsidiary of CureVac NV). In his past career he occupied the position of Executive Director at Novartis Institutes of Biomedical Research, Associate for Howard Hughes Medical Institute, Inc., Associate at The Children's Hospital Corp. and Assistant Professor at Harvard Medical School. Dr. Splawski received a doctorate from the University of Utah and a graduate degree from the University of Sofia.